Susan G. Komen ® Applauds U.S. Supreme Court Decision Protecting No-cost Access to Lifesaving Breast Care
WASHINGTON--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, commends the United States Supreme Court's decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling and testing for some with a personal or family history of breast or related cancers.
The ruling in Braidwood Management, Inc., et al v. Robert Kennedy, Jr., et al upholds the Affordable Care Act's (ACA) requirement that insurers cover services without cost-sharing that receive an A or B rating from the United States Preventive Services Taskforce (USPSTF), a decision Komen hailed as a life-saving victory for millions of Americans.
'This decision is a monumental win for public health and a critical safeguard for the 150 million Americans who depend on no-cost preventive care,' Komen stated. 'Access to screening mammograms, genetic testing, and risk-reducing medications saves lives. Today, the Court affirmed that everyone deserves a fair chance at early detection and preventive care.'
Komen previously submitted an amicus curiae brief urging the Court to protect ACA provisions that have dramatically improved early detection rates and reduced late-stage breast cancer diagnoses.
'This landmark decision gives those affected by breast cancer the support and care they need in order to continue lowering mortality rates across the U.S.,' Komen continued. 'We know breast cancer is most treatable when caught early. Today's decision helps keep hope alive. We thank the Court for recognizing that preventive care is not a luxury—it is a necessity.'
About Susan G. Komen ®
Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
RFK Jr. Wants Every American To Wear A Health-Tracking Device, And Security Experts Have Serious Concerns
If you don't yet wear a smartwatch or smart ring to monitor your health and fitness, you may soon be encouraged to do so by some of the highest-ranking members of the government. During a House Energy and Commerce Health Subcommittee hearing, Health Secretary Robert F. Kennedy Jr. said he'd like all Americans to use wearable health products, such as Fitbits, Apple Watches, Oura Rings, WHOOP and glucose monitors, to 'control' their health and 'take responsibility' for it. According to Poltico, Kennedy said people can use wearables to track 'what food is doing to their glucose levels, their heart rates and a number of other metrics as they eat it, and they can begin to make good judgments about their diet, about their physical activity, about the way that they live their lives.' While this remains just a suggestion and not a mandate, it's been announced that the Department of Health and Human Services will launch a campaign to encourage Americans to wear these devices. Wearables can track your heart rate, menstrual cycle, fitness regimen, blood sugar levels, sleep patterns, location and more. They're a great way to understand your health (for example, the Oura Ring lets you know when it thinks you're getting sick) and to stick to a workout regimen (the Apple Watch is both loved and hated for its 'close your rings' reminders). While they can be helpful for the average person, these devices store lots and lots of our data — is it safe for all of this information to be out there? And what happens if this data ends up in the wrong hands — including the government's? Experts weigh in. First, know that no one has said the government will actually collect this health data. Related: It Turns Out That Most People Wipe Their Butts Completely Wrong, But This Doctor Is Here To Teach Us The Right Way There is a major difference between the government having access to health data and the government simply encouraging folks to use wearables for their own health tracking, said Alex Hamerstone, the advisory solutions director for TrustedSec, an ethical hacking company. 'Those are obviously two very different questions, and there's no indication at this point that they're looking to have the government have access to that data,' he noted. The government does, though, already have access to lots of health data. 'If you look at the percent of people who receive health care through Medicare and Medicaid and state programs, and so on and so forth, they already have a lot of very detailed information,' Hamerstone noted. 'I know there are guardrails around it and things like that, but not to get into any kind of political thing, but a lot of those guardrails seem to be falling down,' he noted. You should also understand that no matter who is privy to it, health data is very valuable. You've probably heard the phrase 'data is the new currency,' meaning your personal data has inherent value to companies. It's how they sell you ads and understand your needs. But 'health data is just kind of a different category of data,' said Hamerstone. Having your credit card hacked is temporarily annoying, but you're not liable, and typically, after some phone calls and logistics, your life will go back to normal. 'But if someone gets access to your private health care data, that's much different. It's a different kind of data,' Hamerstone said. 'So, somebody knowing how many steps you take is one thing, but if you start to get into things like glucose levels or very detailed medical information, those things could start to affect other parts of your life,' he added. This could impact insurance rates and insurance options, Hamerstone said. Some experts are worried about the government's ability to protect health data because of past breaches. Related: Older Women Are Revealing Their Biggest "Life Regrets," And Every Young Person Needs To Hear This Kevin Johnson, the CEO of Secure Ideas, a security testing and consulting company, has concerns about the government's ability to protect any data that is gathered through the use of wearables. For instance, in 2018, there was a major security breach involving the Strava fitness app and the U.S. government in which soldiers' locations at military bases were shared via Strava. 'So, the idea that the government is saying we're going to encourage ... wearing of these when the government had a significant security problem due to this, that's one of the concerns that I just don't understand how we forgot that happened,' said Johnson. Overall, Johnson said, there are 'significant security issues with wearable devices.' 'My company and other companies have tested these devices. We've found vulnerabilities. We have found ways that the wearable technology gives an attacker access to your data because of security lapses in the hardware and software. We've seen multiple cases where attackers are able to gain access to things that are unrelated to the health care data because of security problems,' Johnson said. There have also been privacy violations when data brokers get access to this data, whether they gain access illegitimately or legitimately, Johnson said. (And the companies collecting the data from wearables do often sell your data to data brokers, Johnson noted.) You may not care if someone has your heart rate data from your smartwatch, but it's so much more than 'just' that. 'There are always security concerns when it comes to connected technology,' said Dave Chronister, the CEO of Parameter Security. And your wearable device is most likely connected to your smartphone — meaning it has access to lots of your personal data, according to Johnson. 'No device or platform is completely secure,' Chronister noted. 'Attackers often target the backend systems, such as cloud servers, via compromised employee credentials or software vulnerabilities.' 'Devices that rely on Bluetooth or Wi-Fi can also be exploited, and if the device supports messaging or sync features, phishing or spoofing attacks are possible,' noted Chronister. These devices can also get stolen or lost, which also puts your data at risk, Chronister added. Johnson said he's often heard people say things like, 'Oh, it's just my heart rate data, that's not a big deal,' but it's actually so much more than that. 'The issue is, we're not just talking about heartbeat. We're not just talking about your sleep schedule. We're talking about your location. We're talking about most of these apps tie into your contacts so that you can invite friends,' said Johnson. More, it also may include your reproductive health data, glucose levels or heart irregularities, Chronister said. 'These can paint a sensitive, personal portrait of someone's health and behavior,' Chronister added. Health data from wearables isn't protected like your medical records. 'It's important to understand that data from wearables is not protected under HIPAA like your medical records are,' said Chronister. HIPAA protects patient health records from things like doctor's appointments. 'Instead, it is governed by the company's terms of service ... which often include loopholes that allow for data sharing or sale, especially in the event of a merger or acquisition,' Chronister explained. This is true even if the company says they'll never sell your data. 'That promise can be overridden by fine print or future policy changes,' he added. 'Consumers should be aware that once their data is out there, they may lose control over how it is used,' Chronister said. What can you do to protect your security if you use wearables? 'Almost all of these types of devices have some level of privacy controls in them that you're able to select what data you give,' said Johnson. If you decide to get a wearable, make sure you check your privacy settings and adjust them accordingly, he noted. 'And this is very important — regularly go in and validate that the privacy settings are still set the way you want them to be,' Johnson added. This is really the most you can do to protect your data, and it certainly won't totally protect you from data breaches or data brokers. 'Unfortunately, individual users have very limited control. You are largely at the mercy of the device manufacturer and app provider,' Chronister noted. While you can follow privacy precautions, such as by 'turning off unnecessary Bluetooth connections, using strong account passwords, and checking app permissions ... those measures only go so far,' Chronister said. 'The real issue is how companies store, share and protect your data behind the scenes,' Chronister noted. Chronister stressed that 'it's critical to understand the long-term implications of voluntarily handing over personal health data to private companies. This information can be sold to marketers, shared with third parties, or exposed in a breach.' He voiced specific concern about how this data can be combined via different apps and companies over time to build 'incredibly detailed personal health profiles.' So while it may not be a big deal if one company has your sleep data and another has your activity levels, these companies can be acquired, or data can be combined to create a fuller picture of your private health information. 'And AI is really a wild card. Going forward, it will increasingly be able to draw conclusions and make predictions about your current and future health. This raises serious questions about how such insights could affect things like insurance eligibility, premium rates, or even creditworthiness,' Chronister said. When it comes to health data (and data of any sort), 'the risks are inherent even with the government not involved,' Hamerstone said. Once that data exists, it's at risk of being lost or stolen by bad actors, he added. Keep that in mind before you start using wearable health technology, and if you're already a user, it's important to be aware of the risks so you can make informed decisions and do what you can to protect your article originally appeared on HuffPost. Also in Goodful: This Woman Is Going Viral For Begging Women Not To Get Married Right Now, And Personally, I Couldn't Agree More Also in Goodful: People Are Sharing Their Biggest "How Doesn't Everyone Know This?" Facts, And I'm Honestly Embarrassed I Never Realized Some Of These Also in Goodful: "I Can't Wait For This To Go Out Of Style": People Are Sharing Popular Modern Trends That Are Actually Pretty Toxic
Business Wire
an hour ago
- Business Wire
Chemed To Report Second-Quarter 2025 Earnings July 29, 2025
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarterly earnings update, VITAS internal projections showed that the Florida consolidated program would end the 2025 government fiscal year ending on September 30, 2025 (2025 Cap Year) with a Medicare Cap cushion. Actual Medicare admissions in both April and May 2025 in Florida were weaker than anticipated and lower than VITAS' internal projections. As a result, VITAS now projects a Medicare Cap revenue limitation for the 2025 Cap Year of $18 million to $25 million related to the Florida consolidated program, excluding Tallahassee. The above projection includes actual results through May. Actual June results, which show better admissions than projected through the first half of the month, and actual results in the third quarter could have a significant impact on this projection. Previous guidance for 2025 earnings did not include any Florida Medicare Cap. The source of the Medicare Cap in the Florida consolidated program relates to two factors. The first factor is the 'community access' program. While community access has provided for a higher-than-average ADC growth rate and revenue growth rate at VITAS over the past two years, it adds pressure to the Medicare Cap due to patients accessing hospice care earlier in their disease trajectory. The second factor is the rate differential between the nationally determined increase in the Medicare Cap per admission and the actual reimbursement increase in our Florida consolidated programs, excluding Tallahassee, for the 2025 Cap Year. Specifically, the Medicare Cap per admission amount increased 2.9% while the Florida consolidated program reimbursement increase was 5.2%. VITAS estimates this rate differential will negatively impact the Florida consolidated program's Medicare Cap calculation by approximately $25 million for the 2025 government fiscal year, accounting for most, if not all, of the total revenue limitation discussed above. On June 20, 2025, the State of Florida announced that VITAS has received a Certificate of Need (CON) to begin operating in Pinellas County, Florida. Pinellas is the most densely populated county in Florida and has a hospice utilization rate below the state average. There were approximately 8,600 Medicare admissions to existing hospice providers in Pinellas County in 2024. Entering Pinellas County represents a significant opportunity for VITAS in 2026 and beyond for both overall growth and Medicare Cap mitigation. Based on the new start locations in Florida, primarily Marion County and Pinellas County, combined with operational changes currently being made in the Florida programs, management expects not to have any significant level of Medicare Cap revenue limitation in our Florida consolidated program for the 2026 fiscal year. This expectation assumes that the rate differential discussed above does not recur for the 2026 Cap Year. In the event that the rate differential does recur, VITAS will respond with further mitigation strategies at the outset of the 2026 Cap Year. While less financially significant than the VITAS Medicare Cap situation, during the second quarter of 2025, Roto-Rooter began to experience unexpected weakness in its residential business' demand compared to internal projections. This weakness represents a break from the trends experienced in the first quarter of 2025. Preliminary results for commercial demand in the second quarter of 2025 continue to reflect improved trends but not enough to offset the lower residential demand. Management is in the process of analyzing second quarter performance and the impact of these developments on second quarter results and on full-year 2025 guidance. A full discussion of the analysis will be included with our second quarter 2025 release and related investor conference call. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, July 30, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website Participants may also register via teleconference at: Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time. A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investor relations section of Chemed's website. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services. SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 REGARDING FORWARD-LOOKING INFORMATION Statements in this press release contain forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as 'anticipate,' 'intend,' 'plan,' 'goal,' 'seek,' 'believe,' 'project,' 'estimate,' 'expect,' 'strategy,' 'future,' 'likely,' 'may,' 'should,' 'will' and similar references to future periods and are based upon assumptions subject to certain known and unknown risks, uncertainties, contingencies and other factors, including, but not limited to, the impact of laws and regulations on Chemed's operations, including Medicare Cap and Medicare reimbursement rates, Chemed's estimates of the effect of Medicare Cap on VITAS' revenues and future prospects, Chemed's expectations regarding VITAS' patient mix, VITAS's future prospects in Pinellas County, FL and Chemed's expectations regarding demand for Roter-Rooter's services. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Chemed's control. Chemed's actual results and financial condition may differ materially from those indicated in the forward-looking statements included in this press release, including as a result of the risks described above and those described in the Chemed's Annual Report on Form 10-K for the year ended December 31, 2024 and in its Quarterly Reports filed in 2025. Any forward-looking statement made by Chemed in this press release are based only on information currently available to Chemed and speaks only as of the date on which it is made. Chemed undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Yahoo
an hour ago
- Yahoo
Supreme Court rejects conservative challenge to Obamacare health coverage
WASHINGTON − The Supreme Court on June 27 rejected the latest conservative challenge to the 2010 Affordable Care Act, an attack on free access to cancer screenings, drugs that prevent HIV, cholesterol-lowering medication and other preventive health care services. Two Christian-owned businesses and some people in Texas argued that the experts recommending some of the services health insurance must cover are so powerful that they must be appointed by the president and confirmed by the Senate. In a 6-3 decision, the Supreme Court disagreed, meaning a task force proposing these Obamacare services can continue to do so. But their ruling could give more power to Health and Human Services Secretary Robert F. Kennedy Jr. to decide which services must be available without copays or deductibles. "While today's ruling allows many Americans to breathe a sigh of relief, coverage for this vital care remains at risk," Zachary Baron and Andrew Twinamatsiko, directors of the Center for Health Policy and the Law, said in a statement. "All eyes will turn to the Trump administration to see if Secretary Robert F. Kennedy, Jr. directs the U.S. Preventive Services Task Force to revisit or issue new recommendations that could erode access to preventive care.' The benefit is one of the most popular provisions of the Affordable Care Act − commonly referred to as Obamacare − which has largely survived more than 2,000 lawsuits and multiple trips to the Supreme Court. The latest challenge came from Texans who objected to the requirement that insurers cover the HIV-prevention drug PrEP. They raised religious objections to the drug, saying it encourages same-sex relationships. A federal judge ruled the Christian businesses do not have to include PrEP in their insurance plans. But the judge also said the makeup of the U.S. Preventive Services Task Force, which recommended coverage of PrEP and other preventive services, violates the Constitution's appointments clause. The clause requires presidential appointment and Senate confirmation for officials in significant positions of authority – such as cabinet secretaries and other top agency officials. The Justice Department – both under the Biden and Trump administrations – fought back. The government argued it's the Health and Human Services secretary, and not the task force, that has the 'ultimate responsibility' for whether the experts' recommendations become final. The secretary can fire task force members, review their recommendations and prevent recommendations from taking effect, the Justice Department said during April's oral arguments. The attorney for the Christian businesses said the secretary doesn't have complete control over the task force. Under the law, he noted, tasks force members are supposed to be 'independent and, to the extent practicable, not subject to political pressure.' The government said that independence requirement merely means the task force is supposed to make recommendations based on their impartial medical and public-health judgments. The task force typically updates its recommendations every five years to account for medical advances or reflect new evidence of risk. For example, in 2021, the task force extended recommendations for colon cancer screening to people 45 and older, instead of 50 and up, because of increased diagnoses in younger people. Other services recommended since the ACA was passed include medications like statins to prevent heart disease, lung cancer screenings for certain adults, physical therapy for older people at risk of falling, and testing for hepatitis. Before Obamacare, Americans used preventive services at only about half the recommended rate, according to the federal government. Other services, such as vaccines, that are recommended by different experts, are in dispute under another aspect of the case that is still in the lower courts. This article originally appeared on USA TODAY: Supreme Court rejects conservative challenge to Obamacare
